Advisory Services Network’s Neurocrine Biosciences NBIX Stock Holding History

Advisory Services Network’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24K	Buy	+182	New	+$24.1K	﹤0.01%	3091
2025 Q4	–	Sell	-102	Closed	-$14.3K	–	3380
2025 Q3	$14.3K	Buy	+102	New	+$13.8K	﹤0.01%	3111
2024 Q1	–	Sell	-8	Closed	-$1.05K	–	2839
2023 Q4	$1.05K	Buy	+8	New	+$921	﹤0.01%	3523
2023 Q2	–	Sell	-78	Closed	-$7.89K	–	2818
2023 Q1	$7.89K	Sell	78 -2	-3%	-$208	﹤0.01%	2971
2022 Q4	$9.55K	Buy	+80	New	+$9.37K	﹤0.01%	2882
2021 Q3	–	Sell	-248	Closed	-$24K	–	2561
2021 Q2	$24K	Buy	+248	New	+$23.8K	﹤0.01%	2423
2021 Q1	–	Sell	-306	Closed	-$29K	–	2363
2020 Q4	$29K	Sell	306 -13	-4%	-$1.26K	﹤0.01%	1955
2020 Q3	$30K	Buy	+319	New	+$36.9K	﹤0.01%	1868
2020 Q2	–	Sell	-76	Closed	-$7K	–	2117
2020 Q1	$7K	Sell	76 -643	-89%	-$62.9K	﹤0.01%	2358
2019 Q4	$78K	Buy	719 +666	+1,257%	+$69.7K	﹤0.01%	1271
2019 Q3	$5K	Hold	53	–	–	﹤0.01%	2414
2019 Q2	$5K	Hold	53	–	–	﹤0.01%	2412
2019 Q1	$5K	Buy	53 +10	+23%	+$836	﹤0.01%	2101
2018 Q4	$3K	Buy	+43	New	+$4.12K	﹤0.01%	2216
2018 Q2	–	Sell	-21	Closed	-$2K	–	2619
2018 Q1	$2K	Hold	21	–	–	﹤0.01%	2387
2017 Q4	$2K	Buy	+21	New	+$1.43K	﹤0.01%	2368
2017 Q2	–	Sell	-100	Closed	-$4K	–	2352
2017 Q1	$4K	Buy	+100	New	+$4.28K	﹤0.01%	1801
2016 Q3	$5K	Buy	+100	New	+$4.98K	﹤0.01%	1531

Other funds holding NBIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Services Network's NBIX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Neurocrine Biosciences (NBIX) in Q1 2026: 182 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #3091 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in NBIX as recently as Q3 2025.

Advisory Services Network first reported a position in NBIX in Q3 2016 and has held it in 18 quarters since. The position peaked at $78K in Q4 2019. 694 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

Advisory Services Network held 182 shares of Neurocrine Biosciences worth $24K as of Q1 2026.
Neurocrine Biosciences was a new Advisory Services Network position in Q1 2026.
Neurocrine Biosciences made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3091 holding.
Advisory Services Network first reported a position in Neurocrine Biosciences in Q3 2016 and has held it in 18 quarters since.
Advisory Services Network's Neurocrine Biosciences position peaked at $78K in Q4 2019.
694 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.